AstraZeneca PLC
AZN
$77.50
-$0.46-0.59%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.78% | 4.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.78% | 4.85% | |||
| Cost of Revenue | 14.18% | 13.61% | |||
| Gross Profit | 8.80% | 3.08% | |||
| SG&A Expenses | 8.77% | -5.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -60.00% | 58.33% | |||
| Total Operating Expenses | 12.27% | 2.11% | |||
| Operating Income | 2.05% | 14.31% | |||
| Income Before Tax | -8.86% | -23.74% | |||
| Income Tax Expenses | -57.97% | -15.78% | |||
| Earnings from Continuing Operations | 4.68% | -25.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 100.00% | -300.00% | |||
| Net Income | 4.97% | -25.84% | |||
| EBIT | 2.05% | 14.31% | |||
| EBITDA | -9.45% | 11.56% | |||
| EPS Basic | 4.97% | -25.84% | |||
| Normalized Basic EPS | 1.07% | 18.87% | |||
| EPS Diluted | 5.81% | -26.61% | |||
| Normalized Diluted EPS | 1.07% | 18.72% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.13% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | -- | 124.01% | |||
